Marcela Hrabetova
Pilsen, PL, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Determinants of refined GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies.
Journal: Leukemia research
Published: December 27, 2022
Allogeneic stem cell transplantation in patients with multiple myeloma-single center experience.
Journal: Neoplasma
Published: July 20, 2022
Should We Stop Collecting the Preoperative Autologous Blood before Bone Marrow Harvest?
Journal: Journal of clinical medicine
Published: March 30, 2021
Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 02, 2019
Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission.
Journal: Anticancer research
Published: August 22, 2016
The clinical, histopathological and imaging methods characteristics of Non-Hodgkin lymphomas in patients with brain involvement
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: October 11, 2013
Spontaneous remission of acute myeloid leukemia - a single center case reports
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: May 31, 2013
The incidence of malignancies and surveillance of hematopoietic stem cells donors--the results of the Haemato-Oncology Department University Hospital in Plzen (Pilsen) and Czech National Marrow Donors Registry observation
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: February 22, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026